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Abstract 
Following a request from the European Commission, the EFSA Panel on Additives and Products or 
Substances used in Animal Feed (FEEDAP Panel) was asked to deliver a scientific opinion on the safety 
and efficacy of 17 compounds belonging to chemical group 31 (aliphatic and aromatic hydrocarbons). 
They are currently authorised for use as flavours in food. This opinion concerns eight compounds from 
this group. The FEEDAP Panel concluded that -pinene, -pinene, -caryophyllene, myrcene, 
camphene, -ocimene and δ-3-carene are safe at the proposed maximum dose level (5 mg/kg 
complete feed) for all animal species, except myrcene and β-ocimene when 4 mg/kg would apply for 
cats. For valencene, the calculated safe use level is 1.5 mg/kg complete feed for cattle, salmonids and 
non-food producing animals, and 1.0 mg/kg complete feed for pigs and poultry. No safety concern 
would arise for the consumer from the use of these compounds up to the highest safe levels in feeds. 
The Panel is unable to conclude on user safety in the absence of specific data. The use of the 
compounds in animal nutrition would not pose a risk for the environment provided that the 
concentrations regarded as safe for the target species are not exceeded. As all of the compounds 
under assessment are used in food as flavourings and their function in feed is essentially the same as 
that in food, no further demonstration of efficacy is necessary. However, in the absence of data on 
the stability/survival in water for drinking, the FEEDAP Panel is unable to conclude on the safety or 
efficacy of the substances under this mode of delivery. 
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1. Introduction 
1.1. Background and Terms of Reference 
Regulation (EC) No 1831/2003 1  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7, in addition, Article 10(2) of that Regulation also specifies that 
for existing products within the meaning of Article 10(1), an application shall be submitted in 
accordance with Article 7, within a maximum of seven years after the entry into force of this 
Regulation. 
The European Commission (EC) received a request from Feed Flavourings Authorisation Consortium 
European Economic Interest Grouping (FFAC EEIG)2 for authorisation of 17 substances belonging to 
chemical group 31,3 when used as a feed additive for all animal species (category: sensory additives; 
functional group: flavourings). Chemical group (CG) 31 for flavouring substances is defined in 
Commission Regulation (EC) No 1565/20004 as “aliphatic and aromatic hydrocarbons”. 
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application 
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a 
feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation of an authorised 
feed additive). EFSA received directly from the applicant the technical dossier in support of this 
application. The particulars and documents in support of the application were considered valid by 
EFSA as of 9 June 2010. 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA after verifying the particulars and 
documents submitted by the applicant shall undertake an assessment in order to determine whether 
the feed additive complies with the conditions laid down in Article 5. 
EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the 
environment and on the efficacy of the pin-2(10)-ene, pin-2(3)-ene, -caryophyllene, myrcene, 
camphene, valencene, -ocimene and δ-3-carene, when used under the proposed conditions of use 
(see Section 3.1.3). 
1.2. Additional information 
The initial application concerned 17 compounds assigned to this CG, intended to be used as feed 
flavourings for all animal species. The EFSA Panel on Additives and Products or Substances used in 
Animal Feed (FEEDAP) has already delivered an opinion on nine of the 17 compounds (EFSA FEEDAP 
Panel, 2015). 
The remaining eight compounds were excluded from the previous assessment because the EFSA Panel 
on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) had requested additional 
genotoxicity and toxicity data to complete their assessment. The EFSA CEF Panel has now delivered 
an opinion on the eight compounds, concluding that there are no genotoxicity concerns (EFSA CEF 
Panel, 2015a). 
Consequently, this opinion deals with the eight compounds, namely pin-2(10)-ene (hereafter referred 
to as -pinene) [01.003], pin-2(3)-ene (hereafter referred to as -pinene) [01.004], -caryophyllene 
[01.007], myrcene [01.008], camphene [01.009], valencene [01.017], -ocimene [01.018] and δ-3-
carene [01.029], excluded from the previous opinion. 
                                                          
1  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
2  On 13/03/2013, EFSA was informed by the applicant that FFAC EEIG was liquidated on 19/12/2012 and their rights as 
applicant were transferred to FEFANA asbl (EU Association of Specialty Feed Ingredients and their Mixtures). Avenue Louise 
130A, Box 1, 1050 Brussels, Belgium. 
3  During the course of the assessment, this application was split and the present opinion covers only 8 out of the 17 
substances under application (see 1.2). 
4 Commission Regulation (EC) No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council. OJ L 180, 
19.7.2000, p. 8. 
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The eight compounds are currently listed in the European Union database of flavouring substances5 
and in the European Union Register of Feed Additives, respectively, and thus authorised for use in 
food and feed in the European Union (EU). They have not been previously assessed by EFSA as feed 
additives. 
Regulation (EC) No 429/2008 6 allows substances already approved for use in human food to be 
assessed with a more limited procedure than for other feed additives. However, the use of this 
procedure is always subject to the condition that food safety assessment is relevant to the use in 
feed. 
2. Data and Methodologies 
2.1. Data 
The present assessment is based on data submitted by the applicant in the form of a technical 
dossier7 in support of the authorisation request for the use of the aliphatic and aromatic hydrocarbons 
as a feed additive. The technical dossier was prepared following the provisions of Article 7 of 
Regulation (EC) No 1831/2003 and the applicable EFSA guidance documents. 
The FEEDAP Panel has sought to use the data provided by the applicant together with data from other 
sources, such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientific 
papers and experts’ knowledge, to deliver the present output. 
EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the 
methods used for the control of the aliphatic and aromatic hydrocarbons in animal feed. The Executive 
Summary of the EURL report can be found in Annex A. 
2.2. Methodologies 
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of the aliphatic and 
aromatic hydrocarbons is consistent with the principles laid down in Regulation (EC) No 429/2008 and 
the relevant guidance documents: Guidance for the preparation of dossiers for sensory additives 
(EFSA FEEDAP Panel, 2012a), Technical Guidance for assessing the safety of feed additives for the 
environment (EFSA, 2008, revised in 2009), Guidance for the preparation of dossiers for additives 
already authorised for use in food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety 
of additives for the consumer (EFSA FEEDAP Panel, 2012c) and Guidance on studies concerning the 
safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012d). 
3. Assessment 
3.1. Characterisation 
3.1.1. Characterisation of the flavouring additives 
The molecular structures of the eight additives under application are shown in Figure 1 and their 
physico-chemical characteristics in Table 1. Six compounds are monoterpenes (four bicyclic and two 
acyclic) and the remaining two (-caryophyllene and valencene) are sesquiterpenes. 
 
                                                          
5 Commission Implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances 
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to 
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 
1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1. 
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and 
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1. 
7   FEED dossier reference: FAD-2010-0411. 
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-Pinene (Pin-2(10)-ene) [01.003] 
 
-Pinene (Pin-2(3)-ene) [01.004] 
 
-Caryophyllene [01.007] 
 
Myrcene [01.008] 
 
Camphene [01.009] 
 
Valencene [01.017] 
 
-Ocimene [01.018] 
 
δ-3-Carene [01.029] 
 
 
 
Figure 1:  Molecular structures and FLAVIS numbers of the eight flavouring compounds under 
assessment 
 
Table 1:  Chemical Abstract Services (CAS) and FLAVIS numbers and some characteristics of the 
chemically defined flavourings under assessment 
EU Register name CAS no Flavis no Molecular 
formula 
Molecular 
weight 
Physical 
state 
Log 
Kow
(1) 
Pin-2(10)-ene (-pinene) 127-91-3 01.003 C10H16 136.24  Liquid 4.16 
Pin-2(3)-ene (-pinene) 80-56-8 01.004 C10H16 136.24  Liquid 4.83 
-Caryophyllene  87-44-5 01.007 C15H24 204.36  Liquid 6.3 
Myrcene  123-35-3 01.008 C10H16 136.24  Liquid 4.17 
Camphene  79-92-5 01.009 C10H16 136.24  Solid 4.35 
Valencene 4630-07-3 01.017 C15H24 204.36  Liquid - 
-Ocimene  13877-91-3 01.018 C10H16 136.24  Liquid 4.8 
δ-3-Carene  13466-78-9 01.029 C10H16 136.24  Liquid 4.38 
(1):  Logarithm of octanol–water partition coefficient. 
 
These substances are produced either by chemical synthesis or by extraction from natural sources. 
Several routes of synthesis are available and described in the dossier for all compounds.8 
Batch-to-batch variation data were provided for five batches of each additive, except for -pinene 
[01.004] for which the analysis of four batches was available. The content of the active substance for 
all compounds exceeded the JECFA specifications (Table 2). 
  
                                                          
8
 Technical dossier/Section II. 
Chemical Group 31 (part II) for all animal species  
 
 
 
www.efsa.europa.eu/efsajournal 7 EFSA Journal 2016;14(1):4339 
 
Table 2:  Identity of the substances and data on purity 
EU Register name Flavis no JECFA specification 
minimum % 
Assay % 
Average Range 
Pin-2(10)-ene (-pinene) 01.003 97 99.1 98.5–99.6 
Pin-2(3)-ene (-pinene) 01.004 98 99.0 97.6–99.5 
-Caryophyllene 01.007 80 96.6 90.0–97.2 
Myrcene 01.008 90 93.9 91.2–96.1 
Camphene 01.009 80 95.0 90.5–98.0 
Valencene 01.017 94 96.0 94.4–97.1 
-Ocimene 01.018 80 97.0 88.7–99.4 
δ-3-Carene 01.029 92 95.9 95.5–96.2 
 
Potential contaminants are considered as part of the product specification and are monitored as part 
of the hazard analysis and critical control point (HACCP) procedure applied by all consortium 
members. The parameters considered include residual solvents, heavy metals and other undesirable 
substances. However, no evidence of compliance was provided for these parameters. 
3.1.2. Stability and homogeneity 
The minimum shelf life of the compounds under assessment range from 6 to 24 months when stored 
in closed containers under recommended conditions is determined on the basis of compliance with the 
original specification over this storage period. 
Although no data are required for the stability of volatile additives in pre-mixtures and feed, their use 
in water for drinking introduces other issues relating to product stability, such as degradation due to 
microbial activity. The FEEDAP Panel notes that all these compounds under assessment have very low 
water solubilities (Log Kow > 4), which makes it difficult to assess the safety in water for drinking. 
Considering this, and the absence of data on the short-term stability and homogeneity of the additives 
in water for drinking, the FEEDAP Panel is not in the position to conclude on the use of the additives 
in water for drinking. 
3.1.3. Conditions of use 
The applicant proposes the use of the eight additives in feed or water for drinking for all animal 
species without withdrawal. The normal use level is 1 mg/kg feed and the high use level is 5 mg/kg 
feed. No proposals are made for the dose to be used in water for drinking. 
3.2. Safety 
The assessment of safety is based on the highest use level proposed by the applicant (5 mg/kg 
complete feed). 
3.2.1. Absorption, distribution, metabolism and excretion (ADME) and residue 
studies 
These compounds are readily absorbed from the gastrointestinal tract (WHO, 2005). 
Data on the metabolism of myrcene in rats and rabbits indicate that acyclic alkenes (myrcene and -
ocimene) are metabolised via epoxidation of double bonds, ultimately resulting in diols, which can be 
further conjugated. The principal urinary metabolite following gavage administration of myrcene is 
myrcene-3,10-glycol, formed from the hydration of the epoxide intermediate in both species. 
Epoxidation of the 3,10-double bond was favoured over epoxidation of the 1,2-double bond. The 
studies indicate that the formation of diols from the myrcene-epoxides is very efficient (EFSA CEF 
Panel, 2015a). 
Metabolism data are available for -pinene, -pinene, camphene, δ-3-carene and -caryophyllene 
(bicyclic, non-aromatic hydrocarbons). In general, the metabolic options for these substances include 
oxidation of methyl ring substituent groups to give the corresponding alcohol and further oxidation 
products. For the substances studied, double bond epoxidation has also been demonstrated. In 
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addition, ring cleavage has also been observed, e.g. for -pinene resulting in the formation of 
monocyclic terpenoid derivatives like -terpineol. Hydroxylated metabolites (i.e. alcohols) or further 
metabolic products may be eliminated as conjugates e.g. with glucuronic acid (EFSA CEF Panel, 
2015a). No specific data are available for the metabolism of valencene. 
Little is known about the specific metabolic pathways involved in metabolism of CG 31 compounds in 
livestock. However, the enzymes involved in the biotransformation pathways of these compounds are 
present in all the food-producing target species. The cytochrome P450 monooxygenase families are 
present and have been characterised in a number of food-producing animals, including ruminants, 
horses, pigs (Nebbia et al., 2003; Ioannides, 2006), fish (Wolf and Wolfe, 2005) and birds (Blevins et 
al., 2012). Epoxide hydrolases, the enzymes involved in the detoxication of the epoxides via formation 
of diols, which are then conjugated and eliminated, are present in mammals (Wisniewski et al., 1987; 
Marini et al., 1998), fish (Newman et al., 2001) and birds (Harris et al., 2006). In these species 
(except cats, which have an unusually low capacity for glucuronidation, see Section 3.2.1), 
conjugation reactions with sulphate and glucuronic acid also take place (Watkins and Klaassen, 1986; 
James, 1987), producing water-soluble derivatives that are promptly eliminated in urine. Mammals 
(Watkins and Klaassen, 1986), fish (Espinoza et al. 2013) and birds (Blevins et al., 2012) possess 
glutathione transferases, which mediate the detoxication of the epoxides by conjugation with 
glutathione and elimination of the corresponding mercapturic derivatives. 
In vitro studies showed that some of the compounds under evaluation (-pinene, -pinene, -
ocimene, -myrcene and δ-3-carene) can undergo degradation when incubated with goat rumen 
microbiota (Malecky and Broudiscou, 2009; Malecky et al., 2009). After 24-h incubation, the 
compounds were extensively degraded by the bacteria of the rumen (δ-3-carene to 67%, - and -
pinene to about 80%, and -ocimene at 90%). Broudiscou et al. (2007) also studied the degradation 
of several terpenes in rumen of goats and obtained similar results with an extensive degradation of 
myrcene, -ocimene and -pinene. Haider (2004) investigated the in vitro degradation of a variety of 
essential oil components in bovine rumen content. Among these, some were monoterpenes under 
assessment (- and -pinene, and myrcene). After 24 h of incubation, the monoterpenes disappeared 
almost completely from the incubation medium (only 10% of -pinene was recovered). From these 
studies, it can be concluded that in the rumen some of the compounds under assessment are 
extensively degraded, with the portion absorbed expected to be low as compared with that 
administered. The FEEDAP Panel notes that the degradation products were not identified. 
The presence of some terpenes in products of animal origin, mainly in milk of grazing cows, has been 
described by several authors (e.g. Revello Chion et al., 2010). An oily mixture of -pinene, limonene 
and -caryophyllene (1 g each compound/animal per day, corresponding to about 700 mg/kg feed) 
was orally administered to dairy ewes for 18 days. The three compounds were absorbed, as evidenced 
by their presence in blood, being the lowest levels obtained for -caryophyllene along all the 
experiment, followed by -pinene (Poulopoulou et al., 2012a). In milk, -caryophyllene peaked at the 
7th day of the experiment (about 13 μg/mL), decreasing thereafter, being about 8 μg/mL at the end 
of the trial (about 4 μg/mL for -pinene). Two days after stopping the essential oil administration, 
both -caryophyllene and -pinene were secreted in milk at very low concentrations. In cheese 
prepared with control milk, -pinene and limonene were present, but not -caryophyllene. Both -
pinene and -caryophyllene were present in the treated samples, although limonene was the most 
transferred terpene. The same group (Poulopoulou et al., 2012b) performed a study in goats with a 
similar protocol and found a peak plasma concentration for -caryophyllene (as well as for limonene) 
4 h after the first administration (0.160 μg/mL) and about 0.050 μg/mL for -pinene that almost 
disappeared after 24 h (< 0.01 μg/mL). At the 7th day of administration, the plasma levels peaked 
(about 0.070 μg/mL and 0.050 μg/mL for -caryophyllene and -pinene, respectively) decreasing to 
very low levels (< 0.005 μg/mL) on the 18th day. In milk, -pinene was present at the highest levels, 
attaining almost 1.0 μg/mL on the 18th day, decreasing rapidly thereafter (0.4 μg/mL 2 days after 
stopping the treatment). -Caryophyllene was not detected in milk (limit of detection of the method 
not given). -Pinene and -caryophyllene were present in cheese samples, prepared with milk from 
treated goats, being -pinene also present in control cheese, although at lower concentrations. The 
authors consider that the dose of the compounds used in these experiments is representative of that 
consumed by grazing animals. 
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The transfer of terpenes in milk was also assessed in dairy cows by administering to the animals two 
types of essential oils (caraway and oregano) through duodenal cannulas and by inhalation (Lejonklev 
et al., 2013). Some compounds under assessment were present in these products, namely, -pinene, 
-pinene, -myrcene, δ-3-carene and -caryophyllene. Although the residues of the compounds in 
milk were determined in a total basis, there was a significant increase in the total terpene levels in 
milk obtained immediately after duodenal treatment compared with milk obtained before treatment 
and from the next morning’s milking. Importantly, the total terpene content did not differ in the milk 
samples collected before treatment and the morning following treatment, showing that the transfer of 
compounds into the milk is rapid but short-lived. It has to be noted that the terpenes were introduced 
directly in the duodenum bypassing the degradation by rumen microbiota and that only one 
administration was made although spread for 9 h. 
The accumulation of terpenes in muscle and adipose tissues was investigated in calves (two calves per 
group) fed milk replacer unsupplemented or supplemented with 5 or 20 μL/L of a mixture of essential 
oils. The dose increased from 10 μL essential oil/day at the beginning of the study to 40 μL essential 
oil/day at the end, when animals reached a live weight of about 250 kg (Serrano et al., 2007). There 
was no evidence of increased monoterpene concentrations in tissues of animals supplemented with 
essential oils, but an increase in sesquiterpene concentrations was seen in some adipose tissues of 
one the two treated animals. 
3.2.2. Toxicological studies 
An Organisation for Economic Co-operation and Development OECD 408 compliant 90-day study with 
-caryophyllene (Bauter, 2013a) was assessed by the EFSA CEF Panel (EFSA CEF Panel 2015a). 
Briefly, four groups of rats (10/sex/dietary intake level) of male and female CRL Sprague–Dawley rats 
were fed a diet providing daily intakes of 0, 222, 456 and 1,367 mg -caryophyllene/kg body weight 
(bw) for males and 0, 263, 1,033 and 4,278 mg -caryophyllene/kg bw for females, respectively. At 
the middle and high doses, several adverse effects were observed. Haematological parameters in 
males showed a dose-dependent increase in white blood cells and several changes in other blood 
cells. Pathology and histopathology revealed an increase in the absolute and relative liver weight 
associated with hepatocellular hypertrophy in both sexes, the presence of erythrocytes in the sinuses 
of the mesenteric lymph nodes in both sexes and an increase in relative kidney weight in females, not 
associated with microscopically alterations. Based on the toxicological findings in haematology in 
males, the liver and the mesenteric lymph node pathology in both sexes, and the non-explained 
effects in female kidneys, the EFSA CEF Panel concluded that only the lowest dose in male rats 
(222 mg/kg bw per day) provides a no-adverse-effect level (NOAEL) for -caryophyllene. The FEEDAP 
Panel supports the conclusions by the CEF Panel.  
In an OECD 408 compliant 90-day study with myrcene (Bauter, 2013b), four groups of adult 
Sprague-Dawley rats (10/sex/group) were maintained on diets providing 8.0, 40 and 44 mg 
myrcene/kg bw per day for males, and 9.6, 48 and 53 mg myrcene/kg bw per day for females. There 
were no mortalities, clinical pathological findings, changes in macroscopic or microscopic 
histopathology, or organ weight changes in the groups administered myrcene during the study. Under 
the conditions of the study and based on the toxicological endpoints evaluated, the NOAEL for 
administration of myrcene in the diet was determined to be the highest dose, calculated to provide an 
estimated daily intake of 44 mg/kg bw per day for males and 53 mg/kg bw per day for females, 
respectively. 
The EFSA CEF Panel decided to accept the NOAEL of this study (44 mg/kg bw per day). The FEEDAP 
Panel supports the conclusions by the CEF Panel. 
3.2.3. Safety for the target species 
The first approach to the safety assessment for target species takes account of the applied use levels 
in animal feed relative to the maximum reported exposure of humans on the basis of the metabolic 
body weight. Human exposure in the European Union (EU) to the individual compounds range from 13 
to 1800 μg/person per day (EFSA CEF Panel, 2015b). This corresponds to range from 0.6 to 83 μg/kg 
bw0.75 per day. These exposure levels are considered safe for humans. Table 3 summarises the results 
of the comparison with human exposure for representative target animals. The body weight of target 
animals is taken from the default values shown in Table 4. 
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Table 3:  Comparison of exposure of humans and target animals (calculated from the proposed 
maximum feed concentrations of 5 mg/kg feed) to the flavourings under application 
Flavouring Use level 
in feed 
(mg/kg) 
Human exposure 
(μg/kg bw0.75 per 
day)(1) 
Target animal exposure 
μg/kg bw0.75 per day 
Salmon Piglet Dairy cow 
-Pinene  5 60 118 526 777 
-Pinene 5 83 118 526 777 
-Caryophyllene  5 15 118 526 777 
Myrcene  5 13 118 526 777 
Camphene  5 0.6 118 526 777 
Valencene 5 2.5 118 526 777 
-Ocimene  5 2.6 118 526 777 
δ-3-Carene  5 13 118 526 777 
(1): metabolic body weight (kg bw0.75) for a 60-kg person = 21.6. 
The data in Table 3 show that for all the eight compounds under assessment the intake by target 
animals greatly exceeds that of humans, resulting from use in food. As a consequence, safety for the 
target species at the feed concentration applied cannot be derived from the risk assessment for food 
use. As an alternative, the maximum feed concentration which can be considered safe for the target 
animals can be derived from the lowest NOAEL if suitable data are available.  
Toxicological data (subchronic, repeated-dose studies) were available for -caryophyllene [01.007] 
and myrcene [01.008] from which a NOAEL value could be derived (see Section 3.2.2). In the absence 
of toxicological data, the NOAEL of -caryophyllene (222 mg/kg bw per day) is considered suitable to 
derive a safe feed level for -pinene [01.003], -pinene [01.004], camphene [01.009] and δ-3-carene 
[01.029]. Similarly, the NOAEL of myrcene (44 mg/kg bw per day) could be used to derive a safe level 
in feed for -ocimene [01.018]. As data on the metabolism of valencene [01.017] were not available, 
the FEEDAP Panel did not apply the NOAEL of -caryophyllene to valencene [01.017]. Applying an 
uncertainty factor (UF) of 100 to the NOAELs, the maximum safe intake for the target species was 
derived for the compounds following the EFSA Guidance for sensory additives (EFSA, 2012a), and thus 
the maximum safe feed concentration was calculated (Table 4 and 5). Because glucuronidation of the 
hydrolysis or oxidation products of the compounds in Table 4 and 5 is an important metabolic reaction 
to facilitate the excretion of these compounds (see Section 3.2.1), their use as additives in cat feed 
needs an additional uncertainty factor of 5. This factor was derived from the fact that cats have an 
unusually low capacity for glucuronidation (Court and Greenblatt, 1997). 
Table 4:  Maximum safe concentration in feed for different target animals for -caryophyllene 
[01.007], -pinene [01.003], -pinene [01.004], camphene [01.009] and δ-3-carene 
[01.029] 
Target animal Default values Maximum safe intake/feed concentration 
Body weight 
(kg) 
Feed intake 
(g/day)(1) 
Intake 
(mg/day) 
Concentration 
(mg/kg feed)(2) 
Salmonids 2 40 4 112 
Veal calves (milk replacer)  100 2,000 222 111 
Cattle for fattening  400 8,000 888 111 
Pigs for fattening  100 3,000 222 74 
Sows  200 6,000 444 74 
Dairy cows  650 20,000 1,443 72 
Turkeys for fattening  12 400 27 67 
Piglets  20 1,000 44 44 
Chickens for fattening  2 120 4 37 
Laying hens  2 120 4 37 
Dogs 15 250 33 133 
Cats 3 60 7 22(3) 
(1): Complete feed with 88% DM, except milk replacer for veal calves (94.5% DM), and for cattle for fattening, dairy cows, 
dogs and cats for which the values are DM intake. 
(2): In cattle for fattening, dairy cows, dogs and cats the values are in mg/kg DM intake. 
(3): The uncertainty factor for cats is increased by an additional factor of 5 because of the reduced capacity of glucuronidation. 
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Table 5:  Maximum safe concentration in feed for different target animals for myrcene [01.008] and 
-ocimene [01.018]  
Target animal Default values Maximum safe intake/feed concentration 
Body weight 
(kg) 
Feed intake 
(g/day)(1) 
Intake 
(mg/day) 
Concentration 
(mg/kg feed)(2) 
Salmonids 2 40 1 22 
Veal calves (milk replacer)  100 2,000 44 22 
Cattle for fattening  400 8,000 176 22 
Pigs for fattening  100 3,000 44 15 
Sows  200 6,000 88 15 
Dairy cows  650 20,000 286 14 
Turkeys for fattening  12 400 5 13 
Piglets  20 1,000 9 9 
Chickens for fattening  2 120 1 7 
Laying hens  2 120 1 7 
Dogs 15 250 7 26 
Cats 3 60 1 4(3) 
(1): Complete feed with 88% DM, except milk replacer for veal calves (94.5% DM), and for cattle for fattening, dairy cows, 
dogs and cats for which the values are DM intake. 
(2): In cattle for fattening, dairy cows, dogs and cats the values are in mg/kg DM intake. 
(3): The uncertainty factor for cats is increased by an additional factor of 5 because of the reduced capacity of glucuronidation. 
 
No suitable toxicological study could be identified from which to derive a NOAEL for valencene 
[01.017]. Therefore, the threshold of toxicological concern (TTC) approach was used to derive the 
safe feed concentration for this Cramer Class I compound. This provides a value of 1.5 mg/kg 
complete feed for cattle, salmonids and non-food producing animals, and 1.0 mg/kg complete feed for 
pigs and poultry (EFSA FEEDAP Panel, 2012a). 
Conclusions on safety for the target species 
The FEEDAP Panel concludes that for: 
 -caryophyllene [01.007], -pinene [01.003], -pinene [01.004], camphene [01.009] and 
δ-3-carene [01.029] the proposed maximum use level (5 mg/kg feed) is safe for all target 
species, with a margin of safety ranging from 5 to 23.4-fold; 
 myrcene [01.008] and -ocimene [01.018] the proposed maximum use level (5 mg/kg feed) is 
safe for all target species except cats, with a margin of safety ranging from 1.4 to 4.6-fold. 
For cats, the calculated maximum safe concentration is 4 mg/kg complete feed. 
 valencene [01.017] the calculated safe use level is 1.5 mg/kg complete feed for cattle, 
salmonids and non-food producing animals and 1.0 mg/kg complete feed for pigs and poultry. 
3.2.4. Safety for the consumer 
The consumers are exposed to the compounds under assessment due to their natural occurrence in 
food and use as food flavours. The application as flavours in animal feed would further add to this 
exposure (Section 3.2.1). 
The additional exposure of consumers of products from supplemented animals cannot be calculated 
because much of the available data is qualitative in nature. The only quantitative study identified 
reported a significant increase in the terpene concentrations in milk from supplemented animals 
(Pouloupoulou, 2012b). This study involved a dose considerably higher (700 times) than the proposed 
use level, a dose considered by the authors to be representative of the exposure of grazing animals. 
Data on tissue deposition are scarce. In a preliminary study made in calves, the concentration of 
monoterpenes in adipose tissues appeared not to be influenced by supplementation. 
The FEEDAP Panel recognises the uncertainties introduced by a weak dataset. However, considering 
the data on metabolism and toxicity of the compounds under consideration and the proposed use 
levels, the Panel concludes that supplementation of animals diets with any of the eight compounds 
under assessment would not raise concerns for consumer safety. 
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3.2.5. Safety for the user 
No specific data on the safety for the user were provided. In the material safety data sheets9 hazards 
for skin and eye contact and respiratory, exposure are recognised for the majority of the compounds 
under application. Most are classified as irritating to the respiratory system. No specific data on 
sensitisation were provided. 
3.2.6. Safety for the environment 
The compounds are naturally present in the environment and metabolised by the target species (see 
Section 3.2.1) and expected to be largely excreted as metabolites. Therefore, it is considered that the 
use of the compounds in animal nutrition would not pose a risk for the environment provided that the 
concentrations regarded as safe for the target species are not exceeded. 
3.3. Efficacy 
As all eight compounds are used in food as flavourings, and their function in feed is essentially the 
same as that in food, no further demonstration of efficacy is necessary. 
The FEEDAP Panel does not have information on the possible influence of the compounds on the 
sensory properties of milk and milk products. 
4. Conclusions 
The FEEDAP Panel concludes that -pinene [01.003], -pinene [01.004], -caryophyllene [01.007], 
myrcene [01.008], camphene [01.009], -ocimene [01.018] and δ-3-carene [01.029] are safe at the 
proposed maximum dose level (5 mg/kg complete feed) for all animal species, except myrcene and 
beta-ocimene when 4 mg/kg would apply for cats. For valencene, the calculated safe use level is 
1.5 mg/kg complete feed for cattle, salmonids and non-food producing animals and 1.0 mg/kg 
complete feed for pigs and poultry. 
No safety concern would arise for the consumer when the compounds are used at the safe levels 
identified. 
The Panel is unable to conclude on user safety in the absence of specific data. 
The use of the compounds in animal nutrition would not pose a risk for the environment provided that 
the concentrations regarded as safe for the target species are not exceeded. 
As all of the compounds under assessment are used in food as flavourings and their function in feed is 
essentially the same as that in food, no further demonstration of efficacy is necessary.  
In the absence of data on the stability/survival in water for drinking, the FEEDAP Panel is unable to 
conclude on the safety or efficacy of the substances under this mode of delivery. 
                                                          
9 Technical dossier/Section II/Annex II.3 
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Abbreviations 
 
ADI average daily intake 
ANS EFSA Scientific Panel on Additives and Nutrient Sources added to Food 
bw body weight 
CAS Chemical Abstracts Service 
CD Commission Decision 
CDG chemically defined group 
CEF EFSA Scientific Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids 
CG chemical group 
DM  dry matter 
EC European Commission 
EU European Union 
EURL European Union Reference Laboratory 
FAO Food Agricultural Organization 
FEEDAP EFSA Scientific Panel on Additives and Products or Substances used in Animal Feed 
FFAC Feed Flavourings authorisation Consortium of FEFANA (EU Association of Specialty 
Feed Ingredients and their Mixtures) 
FGE food group evaluation 
FLAVIS EU Flavour Information System 
FL-no FLAVIS number 
GC–MS gas chromatography–mass spectrometry 
GC–MS RTL gas chromatography–mass spectrometry using retention time locking 
HACCP hazard analysis and critical control points 
JECFA Joint FAO/WHO Expert Committee on Food Additives 
LOD limit of detection 
LOQ limit of quantification 
Log Kow logarithm of octanol–water partition coefficient 
bw0.75 metabolic body weight 
MSDI maximised survey-derived daily intake 
MW molecular weight 
NOAEL no observed adverse effect level 
NTP National Toxicology Program 
RTL retention time locking  
TTC threshold of toxicological concern 
UF uncertainty factor 
WHO World Health Organization 
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Annex A – Executive Summary of the Evaluation Report of the European 
Union Reference Laboratory for Feed Additives on the 
Method(s) of Analysis for Aliphatic and aromatic 
hydrocarbons10 
The Chemically Defined Flavourings - Group 31 (CDG31, Aliphatic and aromatic hydrocarbons), in this 
application comprises 17 substances, for which authorisation as feed additives is sought under the 
category ‘sensory additives’, functional group 2(b) ‘flavouring compounds’, according to the 
classification system of Annex I of Regulation (EC) No 1831/2003. 
In the current application submitted according to Article 4(1) and Article 10 (2) of Regulation (EC) No 
1831/2003, the authorisation for all species and categories is requested. The flavouring compounds of 
interest have a purity ranging from 90% to 99% (80% for -Caryophyllene, Camphene and 
-Ocimene). 
Mixtures of flavouring compounds are intended to be incorporated only into feedingstuffs or drinking 
water. The Applicant suggested no minimum or maximum levels for the different flavouring 
compounds in feedingstuffs 
For the identification of volatile chemically defined flavouring compounds CDG31 in the feed additives, 
the Applicant submitted a qualitative multi-analyte gas chromatography–mass spectrometry (GC–MS) 
method, using Retention Time Locking (RTL), which allows a close match of retention times on 
GC-MS. By making an adjustment to the inlet pressure, the retention times can be closely matched to 
those of a reference chromatogram. It is then possible to screen samples for the presence of target 
compounds using a mass spectral database of RTL spectra. The Applicant maintained two FLAVOR2 
databases/libraries (for retention times and for MS spectra) containing data for more than 409 
flavouring compounds. These libraries were provided to the CRL. The Applicant provided the typical 
chromatogram for the CDG31 of interest. 
In order to demonstrate the transferability of the proposed analytical method (relevant for the method 
verification), the Applicant prepared a model mixture of flavouring compounds on a solid carrier to be 
identified by two independent expert laboratories. This mixture contained twenty chemically defined 
flavourings belonging to twenty different chemical groups to represent the whole spectrum of 
compounds in use as feed flavourings with respect to their volatility and polarity. Both laboratories 
properly identified all the flavouring compounds in all the formulations. As the substances of CDG31 
are within the volatility and polarity range of the model mixture tested, the Applicant concluded that 
the proposed analytical method is suitable to determine qualitatively the presence of the substances 
from CDG31 in the mixture of flavouring compounds. 
Based on the satisfactory experimental evidence provided, the CRL recommends for official control for 
the qualitative identification in the feed additive of the individual (or mixture of) flavouring compounds 
of interest listed in Table 1 the GC–MS RTL (Agilent specific) method submitted by the Applicant. 
As no experimental data were provided by the Applicant for the identification of the active 
substance(s) in feedingstuffs and water, no methods could be evaluated. Therefore, the CRL is unable 
to recommend a method for the official control to identify the active substance(s) of interest listed in 
Table 1 in feedingstuffs or water. 
Further testing or validation of the methods to be performed through the consortium of National 
Reference Laboratories as specified by article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
                                                          
10
 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports/fad-2010-
0022?search&form-return 
